https://clinicaltrials.gov/ct2/show/NCT02778919?type=Intr&cond=Endometriosis&lupd_s=05%2F21%2F2019&lupd_d=14
Condition : Endometriosis
Interventions : Drug: KLH-2109; Drug: Placebo; Drug: Leuprorelin acetate
Sponsor : Kissei Pharmaceutical Co., Ltd.
Completed
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
NCT02778919
Fri, 20 May 2016 12:00:00 EDT
Last Update Posted: 06/04/19 07:01AM